Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Outcome Of Board Meeting Held On 10Th August, 2021
In compliance to Regulation 30 and 33 of SEBI Listing Regulations, 2015; we submit the Un-Audited Financial Results of the Company for the quarter ended June 30, 2021; along with the Limited Review Report as issued by M/s Savla & Associates; Statutory Auditors of the Company. Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended 30Th June, 2021
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, August 10, 2021 at 3:00 P.M. at the Registered Office of the Company. Fredun Pharmaceuticals Ltd - 539730 - Shareholding for the Period Ended June 30, 2021
Fredun Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here Fredun Pharmaceuticals Ltd - 539730 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ankita JoshiDesignation :- Company Secretary and Compliance Officer Fredun Pharmaceuticals Ltd - 539730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In compliance to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018; we furnish hereunder the confirmation certificate received from the SEBI Registered Share Transfer Agent viz. Purva Sharegistry (India) Pvt. Ltd. for the quarter ended June 30, 2021. Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, and 'Code of Conduct for Prevention of Insider Trading' of Fredun Pharmaceuticals Limited (hereinafter referred to as the Company), the trading window for dealing in securities of the Company will remain closed for designated persons and their immediate relatives with effect from Thursday, 1st July, 2021 till 48 hours after the end of the Board Meeting wherein; the approval of Un-audited Financial Results for the first quarter ended 30th June, 2021, would be considered, approved and declared. Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In compliance to Regulation 47(1)(b) of SEBI Listing Regulations, 2015; we enclose herewith the copies of the Newspaper cuttings of the Financials Results of the Company for the Quarter and Year ended March 31 2021; as approved by the Board in its Meeting held on Monday, June 28, 2021; published in Business Standard & Mumbai Lakshadeep newspaper(s) on Wednesday, June 30, 2021. Fredun Pharmaceuticals Ltd - 539730 - Non-Applicability Of Regulation 23 (9) Of SEBI (LODR) Regulations, 2015 Regarding Submission Of Disclosures Of Related Party Transactions For The Half Year/ Year Ended 31St March, 2021
This is to certify that in order to comply with Regulation 23 (9) SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Regulation 15 of Chapter IV SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 the paid up equity share capital does not exceed Rs. 10 crores and the Net-worth does not exceed Rs. 25 crores as on the last day of the previous financial year i.e. 31st March, 2021. Therefore, our Company is not required to submit disclosures for related party transactions for the half year /year ended on 31st March, 2021. Fredun Pharmaceuticals Ltd - 539730 - Outcome Of Board Meeting Held On 28Th June, 2021
Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. 28th June, 2021 has inter-alia, considered, adopted and approved Audited Financial Results of the Company for the fourth quarter and financial year ended 31st March, 2021. A copy of Audited Financial Results along with Auditors Report thereon is enclosed herewith. Fredun Pharmaceuticals Ltd - 539730 - Corporate Action-Board approves Dividend
The Board of Directors of the Company at its meeting today i.e. 28th June, 2021 has recommended Dividend of Rs. 0.7/- per share of Rs. 10 each (7 %) for the financial year ended 31st March, 2021 subject to approval of the Shareholders at the ensuing Annual General Meeting of the Company.